SHS closes fourth fund on €125m
German firm SHS Gesellschaft für Beteiligungsmanagement has closed its fourth fund on €125m, exceeding its €100m target.
The fund is more than twice the size of its predecessor, which was launched in September 2006 and held a final close of €50m despite having a target of €70m.
Investors
Commitments to the vehicle came from LPs including pension funds, professional pension insurers, funds-of-funds, family offices, the European Investment Fund and a private health insurance company, the identity of which has not been disclosed. The VC stated its management team also invested a “significant sum” in the fund.
Investments
SHS IV Fonds will make 10-12 minority and majority investments in life sciences and medical technology companies. Its maximum ticket size will be €20m, although it will also take part in larger funding rounds alongside its existing network of co-investors.
The vehicle will specifically target businesses with successor issues and corporate spin-offs.
In 2015 to-date, SHS has invested in Basel-based Advanced Osteotomy Tools, a manufacturer of medical laser systems, and cardiology specialist Vimecon.
People
Hubertus Leonhardt is partner and managing director at SHS.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater